These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17939955)

  • 1. Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature.
    Weisman LE
    Arch Pediatr; 2007 Sep; 14 Suppl 1():S31-4. PubMed ID: 17939955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.
    DeJonge M; Burchfield D; Bloom B; Duenas M; Walker W; Polak M; Jung E; Millard D; Schelonka R; Eyal F; Morris A; Kapik B; Roberson D; Kesler K; Patti J; Hetherington S
    J Pediatr; 2007 Sep; 151(3):260-5, 265.e1. PubMed ID: 17719934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants.
    Shah PS; Kaufman DA
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006449. PubMed ID: 19370635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veronate (Inhibitex).
    Kaufman D
    Curr Opin Investig Drugs; 2006 Feb; 7(2):172-9. PubMed ID: 16499288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants.
    Patel M; Kaufman DA
    Expert Opin Biol Ther; 2015 Apr; 15(4):595-600. PubMed ID: 25736524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.
    Weisman LE; Thackray HM; Garcia-Prats JA; Nesin M; Schneider JH; Fretz J; Kokai-Kun JF; Mond JJ; Kramer WG; Fischer GW
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2879-86. PubMed ID: 19380597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults.
    Weisman LE; Fischer GW; Thackray HM; Johnson KE; Schuman RF; Mandy GT; Stratton BE; Adams KM; Kramer WG; Mond JJ
    Int Immunopharmacol; 2009 May; 9(5):639-44. PubMed ID: 19268719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immune globulin therapy for prevention of nosocomial staphylococcal bloodstream infection in premature infants: not what we hoped for!
    de la Morena MT
    J Pediatr; 2007 Sep; 151(3):232-4. PubMed ID: 17719927
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates.
    Baker CJ; Melish ME; Hall RT; Casto DT; Vasan U; Givner LB
    N Engl J Med; 1992 Jul; 327(4):213-9. PubMed ID: 1614462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive antibiotic administration for prevention of nosocomial septicemia in very small premature infants (VLBW infants)--preventive vancomycin administration against infections with coagulase negative streptococci--prevention of translocation with oral cefixime therapy in intestinal colonization with pathogenic gram-negative pathogens].
    Möller JC; Rossa M; Nachtrodt G; Richter A; Tegtmeyer FK
    Klin Padiatr; 1993; 205(3):140-4. PubMed ID: 8350584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoenhancement to prevent nosocomial coagulase-negative staphylococcal sepsis in very low-birth-weight infants.
    Devlin LA; Lassiter HA
    Clin Perinatol; 2004 Mar; 31(1):69-75. PubMed ID: 15183657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants.
    Bloom B; Schelonka R; Kueser T; Walker W; Jung E; Kaufman D; Kesler K; Roberson D; Patti J; Hetherington S;
    Pediatr Infect Dis J; 2005 Oct; 24(10):858-66. PubMed ID: 16220082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.
    Weisman LE; Thackray HM; Steinhorn RH; Walsh WF; Lassiter HA; Dhanireddy R; Brozanski BS; Palmer KG; Trautman MS; Escobedo M; Meissner HC; Sasidharan P; Fretz J; Kokai-Kun JF; Kramer WG; Fischer GW; Mond JJ
    Pediatrics; 2011 Aug; 128(2):271-9. PubMed ID: 21788224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection.
    John JF
    Curr Opin Mol Ther; 2006 Oct; 8(5):455-60. PubMed ID: 17078388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin.
    Benjamin DK; Schelonka R; White R; Holley HP; Bifano E; Cummings J; Adcock K; Kaufman D; Puppala B; Riedel P; Hall B; White J; Cotton CM;
    J Perinatol; 2006 May; 26(5):290-5. PubMed ID: 16598296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of neonatal late-onset sepsis associated with the removal of percutaneously inserted central venous catheters in preterm infants.
    Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
    Pediatr Crit Care Med; 2011 Jul; 12(4):445-8. PubMed ID: 21263371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units.
    Isaacs D;
    Arch Dis Child Fetal Neonatal Ed; 2003 Mar; 88(2):F89-93. PubMed ID: 12598493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A humanized monoclonal antibody targeting Staphylococcus aureus.
    Patti JM
    Vaccine; 2004 Dec; 22 Suppl 1():S39-43. PubMed ID: 15576200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo.
    Vernachio JH; Bayer AS; Ames B; Bryant D; Prater BD; Syribeys PJ; Gorovits EL; Patti JM
    Antimicrob Agents Chemother; 2006 Feb; 50(2):511-8. PubMed ID: 16436704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection.
    Bloom BT
    Expert Opin Investig Drugs; 2006 Jun; 15(6):703-7. PubMed ID: 16732720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.